Eugen Leo

Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody

Ralf C. Bargou, Eugen Leo, Gerhard Zugmaier et al. · Science · 2008 · 1.1K citations

Life Sciences, Immunology, Oncology +17

Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study

Maria-Elisabeth Goebeler, Stefan Knop, Andreas Viardot et al. · Journal of Clinical Oncology · 2016 · 421 citations

Medicine, Hematology, Oncology +17

TRAF Family Proteins Interact with the Common Neurotrophin Receptor and Modulate Apoptosis Induction

Xin Ye, Patrick Mehlen, Shahrooz Rabizadeh et al. · Journal of Biological Chemistry · 1999 · 185 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Molecular basis for CD40 signaling mediated by TRAF3

Chao‐Zhou Ni, Kate Welsh, Eugen Leo et al. · Proceedings of the National Academy of Sciences · 2000 · 145 citations

Life Sciences, Immunology, Molecular Biology +16

Final Results of a Phase 2 Open-Label, Monotherapy Efficacy and Safety Study of Quizartinib (AC220) in Patients with FLT3-ITD Positive or Negative Relapsed/Refractory Acute Myeloid Leukemia After Second-Line Chemotherapy or Hematopoietic Stem Cell Transplantation

Mark J. Levis, Alexander E. Perl, Hervé Dombret et al. · Blood · 2012 · 141 citations

Medicine, Hematology, Oncology +15